Tuskan awarded Marcus Wallenberg Prize, forestry’s top honor
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A collaboration between the ORNL and a Florida-based medical device manufacturer has led to the addition of 500 jobs in the Miami area to support the mass production of N95 respirator masks.
Growing up in Florida, Emma Betters was fascinated by rockets and for good reason. Any time she wanted to see a space shuttle launch from NASA’s nearby Kennedy Space Center, all she had to do was sit on her front porch.
Experts at the Department of Energy’s 91°µÍø are now offering short-term technical and scientific assistance to entities working to combat the coronavirus through the COVID-19 Technical Assistance Program, an initiative of DOE’s Office of Technology Transitions.
91°µÍø researchers have developed a machine learning model that could help predict the impact pandemics such as COVID-19 have on fuel demand in the United States.
Joe Hagerman, ORNL research lead for buildings integration and controls, understands the impact building technology innovations can have during times of crisis. Over a decade ago, he found himself in the middle of one of the most devastating natural disasters of the century, Hurricane Katrina.
A team led by Dan Jacobson of 91°µÍø used the Summit supercomputer at ORNL to analyze genes from cells in the lung fluid of nine COVID-19 patients compared with 40 control patients.
Ada Sedova’s journey to 91°µÍø has taken her on the path from pre-med studies in college to an accelerated graduate career in mathematics and biophysics and now to the intersection of computational science and biology
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
91°µÍø has launched a program designed to accelerate deployment of innovations that may help fight the COVID-19 pandemic. The COVID-19 Rapid Access Licensing Program will allow companies to license these select technologies at no cost for one year.